18F-Fluoroazomycin Arabinoside

18F氟化硝基咪唑阿拉伯糖苷

Report date: 2025/11/21 17:15:36

Base Information

Drug Name18F-Fluoroazomycin Arabinoside
Drug Alias Name18F标记的氟化硝基咪唑阿拉伯糖苷[18F]Fluoroazomycin arabinoside18-F-FAZA[18F]FAZA
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeRadiation-emitting products > Radioactive diagnostic agent +[4
Mechanisms of ActionDNA-directed DNA polymerase inhibitorsDNA synthesis inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsLung NeoplasmsCarcinoma, Renal CellRhabdomyosarcoma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesIrccs San Raffaele
Active IndicationsLung NeoplasmsRhabdomyosarcomaNeoplasms
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A